Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 74, 2019 - Issue 5
154
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Conservative treatment of recurrent symptoms of an incomplete, atypical femoral fracture associated with glucocorticoid, bisphosphonate, and denosumab therapy in a patient with chronic obstructive pulmonary disease

, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 370-374 | Published online: 19 Oct 2018

References

  • Lin CH, Chen KH, Chen CM, et al. Risk factors for osteoporosis in male patients with chronic obstructive pulmonary disease in Taiwan. PeerJ. 2018 Jan;12(6):e4232.
  • Lin CW, Chen YY, Chen YJ, et al. Prevalence, risk factors and health-related quality of life of osteoporosis in patients with COPD at a community hospital in Taiwan. Int J Chron Obstruct Pulmon Dis. 2015 Jul;29(10):1493–1500.
  • Yamauchi Y, Yasunaga H, Sakamoto Y, et al. Mortality associated with bone fractures in COPD patients. Int J Chron Obstruct Pulmon Dis. 2016 Sep;11(11):2335–2340.
  • Unnanuntana A, Saleh A, Mensah KA, et al. Atypical femoral fractures: what do we know about them? J Bone Joint Surg Am. 2013 Jan 16;2(95):e81–13.
  • Sato H, Kondo N, Wada Y, et al. The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates. Osteoporos Int. 2016 Mar;27(3):1217–1225.
  • Koh A, Guerado E, Giannoudis PV. Atypical femoral fractures related to bisphosphonate treatment: issues and controversies related to their surgical management. Bone Joint J.. 2017 Mar;99-B(3):295–302.
  • Favinger JL, Hippe D, Ha AS. Long-term radiographic follow-up of bisphosphonate-associated atypical femur fractures. Skeletal Radiol. 2016 May;45(5):627–633.
  • Oh CW, Oh JK, Park KC, et al. Prophylactic nailing of incomplete atypical femoral fractures. ScientificWorldJournal. 2013;2013:450148.
  • Shane E, Burr D, Abrahamsen B, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014 Jan;29(1):1–23.
  • Mahjoub Z, Jean S, Leclerc JT, et al. Incidence and characteristics of atypical femoral fractures, clinical and geometrical data. J Bone Miner Res. 2016 Apr;31(4):767–776.
  • Hagen JE, Miller AN, Ott SM, et al. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry. J Bone Joint Surg Am. 2014 Nov 19;96(22):1905–1909.
  • Villiers J, Clark DW, Jeswani T, et al. An atraumatic femoral fracture in a patient with rheumatoid arthritis and osteoporosis treated with denosumab. Case Rep Rheumatol. 2013;2013:249872.
  • Drampalos E, Skarpas G, Barbounakis N, et al. Atypical femoral fractures bilaterally in a patient receiving denosumab. Acta Orthop. 2014 Feb;85(1):3–5.
  • Ramchand SK, Chiang CY, Zebaze RM, et al. Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report. Osteoporos Int. 2016 Feb;27(2):821–825.
  • Selga J, Nuñez JH, Minguell J, et al. Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review. Osteoporos Int. 2016 Feb;27(2):827–832.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.